ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Called “Unscrupulous” in Abramson Lawsuit, Thompson Calls Abramson A Rich Man Scorned

March 23, 2012

Marijuana-Derived Drug Less Effective Than Standard

March 29, 2002

“Acceptable” Images Found In Chest Scans Using Half Dose

August 30, 2002

Bernard Fisher Settles Suit For $2.7M, Retains title, University Apologizes

September 5, 1997

Letter to the Editor: A Victory for Research, But Real Work Is Ahead

November 26, 1999

DCE Board Gives Concept Approval To Eight Contract Recompetitions

July 20, 1984